🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
The purpose of the primary phase of the study is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-01
Trial ID
NCT00326118
The purpose of this Phase IIIb study is to evaluate the immunogenicity, rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12-01
Trial ID
NCT00586612
Treatments Being Tested
The purpose of this study is to assess the safety in terms of fever (rectal...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-25
Trial ID
NCT00463437
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested
The trial includes groups receiving various combinations of meningitis C an...
Status
Completed
Location
Gloucestershire primary care
Start Date
2013-09
Trial ID
NCT02526394
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-03
Trial ID
NCT01777308
Treatments Being Tested